SUMMARY DNA was analysed from 33 patients with congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency. In each case Southern blots were prepared from a number of restriction enzyme digests and hybridised with probes for both the 21-hydroxylase and the adjacent fourth component of complement (C4).
The genes coding for the steroid 21-hydroxylase enzyme (EC 1.14.99.10, CYP21) are located on the short arm of chromosome 6, 3' to the genes coding for the fourth component of complement, C4A and C4B. Deficiency of this enzyme leads to congenital adrenal hyperplasia (CAH) and has been shown to be caused by a heterogeneous range of defects, including deletions of the active (21-hydroxylase B) IBglIIIEcoRI showed a deletion of the 2-4 kb band located at the 5' end of 21B and not of the 3' 8 kb band (fig 3a) . One other SL case was heterozygous for a 'deleted'/'converted' CYP21B (fig 3b) . Two patients (1 SL, 1 SV) in whom the CYP21B gene appeared to be intact had the C4A-CYP21A genes deleted on one chromosome. This led to a reduced intensity of the 3-2 kb TaqI, 4 kb KpnI, and 10 kb EcoRIIBglII bands with probe K, in addition to the presence of the 6-4 kb TaqI fragment detected with probe A, a marker for deletion of the C4A gene9 (fig 2, lane 5 The most important finding in this study is the range of genetic defects which can give rise to the clinical presentation of 21-hydroxylase deficiency. The interpretation of results in these patients is difficult and requires the use of more than one restriction enzyme and probes for both C4 and 21-hydroxylase.
In those cases in which a normal restriction fragment pattern is evident, one can only assume that an undetected point mutation is present in either the gene or flanking sequences. Rodrigues et al1 cloned a single intact, but presumably defective, CYP21B gene and found a total of 11 nucleotide differences, two of which were in exons leading to amino acid substitutions in the protein molecule. In the same patient, there was also some evidence for partial 'gene conversion', the defective 21B containing some changes which gave rise to the nucleotide sequence found in the CYP21A gene. Two unrelated patients in our study show 
